(19)
(11) EP 1 487 782 A1

(12)

(43) Date of publication:
22.12.2004 Bulletin 2004/52

(21) Application number: 03763310.4

(22) Date of filing: 03.07.2003
(51) International Patent Classification (IPC)7C07C 231/02, C07C 231/24, C07C 233/63, C07C 51/60, C07C 61/08
(86) International application number:
PCT/US2003/021238
(87) International publication number:
WO 2004/005240 (15.01.2004 Gazette 2004/03)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 03.07.2002 US 393495 P
18.07.2002 US 396904 P
25.09.2002 US 413622 P
26.09.2002 US 414199 P
05.11.2002 US 423750 P
10.12.2002 US 432093 P
12.12.2002 US 432962 P
23.01.2003 US 442109 P
24.02.2003 US 449791 P
16.06.2003 US 479016 P

(71) Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
49131 Petah Tiqva (IL)

(72) Inventors:
  • YAHALOMI, Ronit
    27 Kiryat Bialik (IL)
  • SHAPIRO, Evgeny
    32922 Haifa (IL)
  • DOLITZKY, Ben-Zion
    49651 Petach Tiqva (IL)
  • GOZLAN, Yigael
    32922 RamotSapir (IL)

(74) Representative: Nachshen, Neil Jacob et al
D Young & Co120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) PROCESS FOR PREPARING NATEGLINIDE AND INTERMEDIATES THEREOF